Antineutrophil Cytoplasmic Antibody-associated Vasculitis
33
13
16
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
6.1%
2 terminated out of 33 trials
75.0%
-11.5% vs benchmark
21%
7 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (33)
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
Study of Salvage Therapy to Treat Patients with Granulomatosis with Polyangiitis
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases